biotech · Pulmonary Arterial Hypertension · Pulmonary Arterial Hypertension (PAH) · IKT
Inhibikase Therapeutics
Inhibikase Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.
Wilmington, USA HQ
29 Employees
Public company Type
IKT · NYSE Ticker
Company details
- Status
- Public
- HQ
- Wilmington, USA
- Employees
- 29
- Programs
- 4
- Drugs
- 5
- Patents
- 9
Inhibikase Therapeutics clinical trials
Registry index of 4 ClinicalTrials.gov studies linked to Inhibikase Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Inhibikase Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Inhibikase Therapeutics.